AKT3 and non-small cell lung carcinoma: However, no significant associations were observed between AKT3 or FGFR2 expression levels and either the TNM stage or overall survival time in NSCLC patients (Supplementary Fig. 2b & c), highlighting the distinctiveness of PPLELC.